microvessels (Jackson Immuno)
Structured Review

Microvessels, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 4486 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microvessels/product/Jackson Immuno
Average 96 stars, based on 4486 article reviews
Images
1) Product Images from "Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease."
Article Title: Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease.
Journal: Nature
doi: 10.1038/s41586-025-08589-9
Figure Legend Snippet: Fig. 3 | Reduced brain endothelial mucin-type O-glycosylation increases BBB leakiness and brain bleeding. a, Overview of AAV-mediated C1galt1 knockdown paradigm. ITR, inverted terminal repeat. b, C1GALT1 expression and mucin-domain glycoprotein labelling in acutely isolated microvessels. Scale bars, 10 µm. c, Quantification of C1GALT1 expression in b (n = 5 mice per group, two-sided t-test; mean ± s.e.m.). d, Quantification of mucin-domain glycoprotein labelling in b (n = 5, two-sided t-test; mean ± s.e.m.). e, Sulfo-NHS-biotin leakage in the cortices of young mice transduced with AAV-EGFP and AAV-miR-C1galt1. Scale bars, 500 µm. f, Sulfo-NHS-biotin leakage (indicated by white arrowheads) from EGFP+ cortical vessels of AAV-miR-C1galt1-transduced mice. Scale bars, 50 µm. g, Quantification of vessel permeability in f (n = 5 mice per group; two-sided t-test; mean ± s.e.m.). h, Overview of luminal mucin-domain glycoprotein degradation paradigm using 48 h StcE treatment. H&E, haematoxylin and eosin. i, Whole-brain images of sulfo-NHS-biotin leakage in mice treated with StcE for 48 h.
Techniques Used: Glycoproteomics, Knockdown, Expressing, Isolation, Transduction, Permeability
Figure Legend Snippet: Fig. 4 | Restoration of mucin-type O-glycosylation improves BBB function in aged mice. a, Overview of C1GALT1 and B3GNT3 overexpression paradigm and relevant AAV constructs. b, C1GALT1 expression in acutely isolated microvessels labelled with LEL. Scale bars, 10 µm. c, Quantification of b (n = 5 mice per group; two-sided t-test; mean ± s.e.m.). d, B3GNT3 expression in acutely isolated microvessels labelled with LEL. Scale bar = 10 µm. e, Quantification of d (n = 5 mice per group; one-way ANOVA with Dunnett’s post hoc test; mean ± s.e.m.). f, Quantification of mucin-domain glycoprotein labelling in acutely isolated microvessels (n = 5 mice per group; two-sided t-test; mean ± s.e.m.).
Techniques Used: Glycoproteomics, Over Expression, Construct, Expressing, Isolation

